Ocular Inflammation [clinicaltrials_resource:a32e9ddb740b99af960d339637365c72]
Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery [clinicaltrials:NCT00353964]clinicaltrials:NCT00645671clinicaltrials:NCT00699153Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification [clinicaltrials:NCT00789971]Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers [clinicaltrials:NCT01190878]clinicaltrials:NCT01214174Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers. [clinicaltrials:NCT01535443]clinicaltrials:NCT01721694RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD [clinicaltrials:NCT02128113]
condition [clinicaltrials_vocabulary:condition]
Ocular Inflammation [clinicaltrials_resource:a32e9ddb740b99af960d339637365c72]
Bio2RDF identifier
a32e9ddb740b99af960d339637365c72
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a32e9ddb740b99af960d339637365c72
identifier
clinicaltrials_resource:a32e9ddb740b99af960d339637365c72
title
Ocular Inflammation
@en
label
Ocular Inflammation [clinicaltrials_resource:a32e9ddb740b99af960d339637365c72]
@en